Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1998 1
2000 2
2001 1
2003 1
2004 2
2018 1
2019 1
2020 4
2021 5
2022 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Anti-SARS-CoV-2 vaccines in recipient and/or donor before allotransplant.
Jullien M, Coste-Burel M, Clemenceau B, Letailleur V, Guillaume T, Peterlin P, Garnier A, Bourgeois AL, Imbert BM, Ollier J, Grain A, Touzeau C, Moreau P, Béné MC, Vié H, Chevallier P. Jullien M, et al. Among authors: imbert bm. EJHaem. 2022 Feb 17;3(2):484-487. doi: 10.1002/jha2.398. eCollection 2022 May. EJHaem. 2022. PMID: 35313664 Free PMC article.
Lopinavir pharmacokinetics in COVID-19 patients.
Gregoire M, Le Turnier P, Gaborit BJ, Veyrac G, Lecomte R, Boutoille D, Canet E, Imbert BM, Bellouard R, Raffi F. Gregoire M, et al. Among authors: imbert bm. J Antimicrob Chemother. 2020 Sep 1;75(9):2702-2704. doi: 10.1093/jac/dkaa195. J Antimicrob Chemother. 2020. PMID: 32443151 Free PMC article. No abstract available.
Interest of a third dose of BNT162b2 anti-SARS-CoV-2 messenger RNA vaccine after allotransplant.
Le Bourgeois A, Coste-Burel M, Guillaume T, Peterlin P, Garnier A, Imbert BM, Drumel T, Mahé B, Dubruille V, Blin N, Lok A, Touzeau C, Gastinne T, Tessoulin B, Jullien M, Vantyghem S, Moreau P, Le Gouill S, Béné MC, Chevallier P. Le Bourgeois A, et al. Among authors: imbert bm. Br J Haematol. 2022 Mar;196(5):e38-e40. doi: 10.1111/bjh.17911. Epub 2021 Oct 20. Br J Haematol. 2022. PMID: 34671982 Free PMC article. No abstract available.
Safety and antibody response after one and/or two doses of BNT162b2 Anti-SARS-CoV-2 mRNA vaccine in patients treated by CAR T cells therapy.
Gastinne T, Le Bourgeois A, Coste-Burel M, Guillaume T, Peterlin P, Garnier A, Imbert BM, Drumel T, Mahe B, Dubruille V, Blin N, Lok A, Touzeau C, Tessoulin B, Jullien M, Vanthygem S, Béné MC, Moreau P, Le Gouill S, Chevallier P. Gastinne T, et al. Among authors: imbert bm. Br J Haematol. 2022 Jan;196(2):360-362. doi: 10.1111/bjh.17818. Epub 2021 Sep 2. Br J Haematol. 2022. PMID: 34476803 Free PMC article. No abstract available.
Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipients.
Chevallier P, Coste-Burel M, Le Bourgeois A, Peterlin P, Garnier A, Béné MC, Imbert BM, Drumel T, Le Gouill S, Moreau P, Mahe B, Dubruille V, Blin N, Lok A, Touzeau C, Gastinne T, Jullien M, Vanthygem S, Guillaume T. Chevallier P, et al. Among authors: imbert bm. EJHaem. 2021 Jun 1;2(3):520-524. doi: 10.1002/jha2.242. eCollection 2021 Aug. EJHaem. 2021. PMID: 34226903 Free PMC article.
B Cell Aplasia Is the Most Powerful Predictive Marker for Poor Humoral Response after BNT162b2 mRNA SARS-CoV-2 Vaccination in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.
Jullien M, Le Bourgeois A, Coste-Burel M, Peterlin P, Garnier A, Rimbert M, Imbert BM, Le Gouill S, Moreau P, Mahe B, Dubruille V, Blin N, Lok A, Touzeau C, Gastinne T, Tessoulin B, Vantyghem S, Béné MC, Guillaume T, Chevallier P. Jullien M, et al. Among authors: imbert bm. Transplant Cell Ther. 2022 May;28(5):279.e1-279.e4. doi: 10.1016/j.jtct.2022.02.018. Epub 2022 Feb 24. Transplant Cell Ther. 2022. PMID: 35218998 Free PMC article.
Interaction of anti-HLA antibodies with pig xenoantigens.
Barreau N, Godfrin Y, Bouhours JF, Bignon JD, Karam G, Leteissier E, Moreau A, Dantal J, Menoret S, Anegon I, Imbert BM, Brouard S, Soulillou JP, Blancho G. Barreau N, et al. Among authors: imbert bm. Transplantation. 2000 Jan 15;69(1):148-56. doi: 10.1097/00007890-200001150-00025. Transplantation. 2000. PMID: 10653394
Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021.
Gaymard A, Bosetti P, Feri A, Destras G, Enouf V, Andronico A, Burrel S, Behillil S, Sauvage C, Bal A, Morfin F, Van Der Werf S, Josset L; ANRS MIE AC43 COVID-19; French viro COVID group; Blanquart F, Coignard B, Cauchemez S, Lina B. Gaymard A, et al. Euro Surveill. 2021 Mar;26(9):2100133. doi: 10.2807/1560-7917.ES.2021.26.9.2100133. Euro Surveill. 2021. PMID: 33663644 Free PMC article.
Grade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamide.
Chevallier P, Berceanu A, Peterlin P, Garnier A, Le Bourgeois A, Imbert BM, Daguindau E, Mahé B, Dubruille V, Blin N, Touzeau C, Gastinne T, Lok A, Tessoulin B, Vantyghem S, Desbrosses Y, Bressollette C, Duquesne A, Eveillard M, Le Bris Y, Dormoy A, Malugani C, Deconinck E, Moreau P, Le Gouill S, Béné MC, Guillaume T. Chevallier P, et al. Among authors: imbert bm. Acta Oncol. 2021 Apr;60(4):466-474. doi: 10.1080/0284186X.2020.1837947. Epub 2020 Oct 28. Acta Oncol. 2021. PMID: 33112687
20 results